SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31 | -8.8% | 19,220 | +70.1% | 0.00% | -25.0% |
Q2 2023 | $34 | +61.9% | 11,300 | +197.4% | 0.00% | +100.0% |
Q1 2023 | $21 | 0.0% | 3,800 | -2.6% | 0.00% | 0.0% |
Q4 2022 | $21 | -99.9% | 3,900 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $25,000 | +92.3% | 3,900 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $13,000 | -51.9% | 3,900 | -2.5% | 0.00% | 0.0% |
Q1 2022 | $27,000 | -47.1% | 4,000 | -68.3% | 0.00% | -50.0% |
Q4 2021 | $51,000 | -10.5% | 12,600 | -17.4% | 0.00% | 0.0% |
Q3 2021 | $57,000 | -25.0% | 15,261 | +376.9% | 0.00% | -50.0% |
Q2 2021 | $76,000 | +300.0% | 3,200 | -3.0% | 0.00% | +300.0% |
Q1 2021 | $19,000 | -48.6% | 3,300 | -38.9% | 0.00% | -50.0% |
Q4 2020 | $37,000 | -82.7% | 5,400 | -73.0% | 0.00% | -84.6% |
Q3 2020 | $214,000 | +328.0% | 19,987 | +88.6% | 0.01% | +333.3% |
Q2 2020 | $50,000 | +35.1% | 10,600 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $37,000 | +2.8% | 10,600 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $36,000 | -14.3% | 10,600 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $42,000 | +23.5% | 10,600 | 0.0% | 0.00% | +33.3% |
Q2 2019 | $34,000 | -52.8% | 10,600 | 0.0% | 0.00% | -57.1% |
Q1 2019 | $72,000 | +56.5% | 10,600 | +2.1% | 0.01% | +75.0% |
Q4 2018 | $46,000 | -41.0% | 10,384 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $78,000 | -12.4% | 10,384 | 0.0% | 0.01% | -28.6% |
Q2 2018 | $89,000 | +1.1% | 10,384 | -16.1% | 0.01% | 0.0% |
Q1 2018 | $88,000 | -25.4% | 12,384 | 0.0% | 0.01% | +40.0% |
Q4 2017 | $118,000 | -30.6% | 12,384 | +6.0% | 0.01% | -16.7% |
Q3 2017 | $170,000 | +1.8% | 11,684 | -21.1% | 0.01% | 0.0% |
Q2 2017 | $167,000 | -7.7% | 14,800 | -44.2% | 0.01% | -14.3% |
Q1 2017 | $181,000 | +15.3% | 26,500 | +52.3% | 0.01% | +40.0% |
Q4 2016 | $157,000 | +166.1% | 17,400 | -70.9% | 0.01% | +66.7% |
Q3 2016 | $59,000 | -4.8% | 59,747 | +245.4% | 0.00% | -25.0% |
Q2 2016 | $62,000 | -67.5% | 17,300 | -4.1% | 0.00% | -69.2% |
Q1 2016 | $191,000 | +48.1% | 18,047 | -49.2% | 0.01% | +62.5% |
Q4 2015 | $129,000 | – | 35,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
Knott David M Jr | 70,000 | $167 | 0.06% |
XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |